Patent details

EP2925366 Title: PHARMACEUTICAL COMBINATIONS

Basic Information

Publication number:
EP2925366
PCT Application Number:
US2013071852
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138028154
PCT Publication Number:
WO2014085381
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMBINATIONS
French Title of Invention:
COMBINAISONS PHARMACEUTIQUES
German Title of Invention:
PHARMAZEUTISCHE KOMBINATIONEN
SPC Number:

Dates

Filing date:
26/11/2013
Grant date:
21/02/2018
EP Publication Date:
07/10/2015
PCT Publication Date:
05/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/02/2018
EP B1 Publication Date:
21/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/02/2018
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
ARONOVA S.A.
From:
25/05/2018
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
EMERY, Caroline
Address:
United States (US)

2

Name:
PORTER, Dale
Address:
United States (US)

3

Name:
TAN, Lujian
Address:
United States (US)

4

Name:
YERRAMILLI-RAO, Padmaja
Address:
United States (US)

Priority

1

Priority Number:
201261731174 P
Priority Date:
29/11/2012
Priority Country:
United States (US)

2

Priority Number:
201261731555 P
Priority Date:
30/11/2012
Priority Country:
United States (US)

3

Priority Number:
201361755520 P
Priority Date:
23/01/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4184; A61K 31/517; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201808
Publication date:
21/02/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/10/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
06/06/2018 Outgoing Correspondence 1
25/05/2018 Power Of Attorney 1